stockrow
Friday 6 November 2026
Export NNOX’s income statement to Excel — free account
Nano-X Imaging Ltd.
NNOX Healthcare Medical Devices
Nano-X Imaging Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $13.0 million, up 15.4% from fiscal 2024.
- Revenue
- +36.7%
- EPS
- −243.5%
- Free cash flow
- −21.4%
- Total debt
- −12.0%
Quarter to June 2026, against a year earlier
0.24
0.01
−4.00%
Follow NNOX
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 1 | 9 | 10 | 11 | 13 | 16 | +77.8% | 22 | 41 | 50 | +56.9% | |
| Gross margin, % | — | — | 0.00 | 0.00 | 0.00 | (115.95) | (80.21) | (66.55) | (94.03) | (98.21) | (337.50) | (98.2) pt | ||||||
| EBT | — | — | (2) | (23) | (44) | (62) | (117) | (61) | (54) | (77) | (119) | +69.5% | ||||||
| EBT margin, % | — | — | 0.00 | 0.00 | 0.00 | (4,742.79) | (1,363.03) | (617.01) | (477.48) | (589.89) | (758.47) | (589.9) pt | ||||||
| Net income | — | 0 | (2) | (23) | (44) | (62) | (113) | (61) | (54) | (75) | (117) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | 0.00 | 0.00 | 0.00 | 0.03 | 0.16 | 0.18 | 0.19 | 0.20 | 0.22 | n/m | |||||
| Earnings | — | — | (0.09) | (0.90) | (1.23) | (1.26) | (2.01) | (1.08) | (0.91) | (1.16) | (1.70) | +43.7% | ||||||
| Cash flow | — | — | (0.18) | (0.22) | (0.60) | (0.79) | (0.83) | (0.79) | (0.62) | (0.63) | (0.67) | +19.9% | ||||||
| Capex | — | — | 0.00 | 0.00 | (0.39) | (0.48) | (0.14) | (0.06) | (0.05) | (0.06) | (0.08) | +51.8% | ||||||
| Free cash flow | — | — | (0.18) | (0.22) | (0.99) | (1.27) | (0.97) | (0.85) | (0.67) | (0.69) | (0.74) | +21.3% | ||||||
| Book value | — | — | (0.31) | (0.35) | 6.47 | 6.06 | 4.15 | 3.47 | 3.22 | 2.16 | 1.04 | n/m | ||||||
| Shares, m | — | — | 21 | 25 | 36 | 48 | 52 | 56 | 59 | 65 | 67 | +17.6% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | |||||
| P/S | — | — | — | — | — | 0.00 | 43.42 | 36.76 | 37.44 | 13.93 | 1.07 | 26.3 | ||||||
| P/B | — | — | — | — | — | 2.40 | 1.72 | 1.86 | 2.23 | 1.30 | 0.23 | 1.9 | ||||||
| EV/Sales | — | — | — | — | — | 0.00 | 34.86 | 29.13 | 32.89 | 10.66 | (0.51) | 21.5 | ||||||
| EV/FCF | — | — | — | — | — | (10.07) | (5.91) | (6.00) | (9.43) | (3.08) | 0.15 | (6.9) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | (4) | (6) | (21) | (38) | (43) | (45) | (37) | (41) | (47) | +41.1% | |||||
| Capex | — | — | 0 | 0 | (14) | (23) | (7) | (3) | (3) | (4) | (5) | +78.5% | ||||||
| Free cash flow | — | — | (4) | (6) | (35) | (61) | (51) | (48) | (39) | (45) | (52) | +42.6% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | (7) | (11) | 215 | 42 | 57 | 73 | 65 | 50 | 25 | n/m | |||||
| Net debt | — | — | 0 | (8) | (212) | (85) | (73) | (79) | (55) | (46) | (28) | +268.4% | ||||||
| Shareholders’ equity | — | — | (6) | (9) | 231 | 292 | 217 | 196 | 189 | 140 | 72 | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | (205.82) | (328.76) | (35.33) | (20.62) | (36.70) | (25.72) | (24.97) | (40.31) | (84.82) | +165.5 pt | |||||
| ROIC | — | — | 0.00 | 0.00 | (146.64) | (18.55) | (51.35) | (33.56) | (26.37) | (52.17) | (168.62) | (52.2) pt | ||||||
| ROE | — | — | 25.18 | 297.63 | (39.48) | (23.64) | (44.51) | (29.49) | (27.83) | (45.62) | (98.98) | (70.8) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | 21 | 50 | 186 | 180 | 164 | 165 | 197 | — | +45.2% | |||||
| Revenue/emp, $m | — | — | — | 0.00 | 0.00 | 0.01 | 0.05 | 0.06 | 0.07 | 0.07 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026
Nano-X Imaging Ltd. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| ELUT Elutia Inc. | $33.3M | 0.6× | — (loss-making) | −11.65% (below 0%: shrinking) | n/m | −2.52% (below 0%: shrinking) | 59.62% | (327.85%) | Compare |
| RPID Rapid Micro Biosystems, Inc. | $31.1M | — (loss-making) | — (loss-making) | +10.91% (above 0%: growing) | n/m | −23.97% (below 0%: shrinking) | 15.05% | (152.99%) | Compare |
| QTI QT Imaging Holdings, Inc. | $30.3M | — (loss-making) | — (loss-making) | +103.20% (above 0%: growing) | n/m | −236.31% (below 0%: shrinking) | 41.16% | (25.07%) | Compare |
| NSYS Nortech Systems Incorporated | $30.0M | 28.4× | 17.5× | +9.34% (above 0%: growing) | −8.33% (below 0%: shrinking) | −1,567.16% (below 0%: shrinking) | 17.00% | 1.86% | Compare |
| NNOX Nano-X Imaging Ltd. | $19.6M | — (loss-making) | — (loss-making) | +36.71% (above 0%: growing) | n/m | −21.37% (below 0%: shrinking) | (1,050.87%) | (1,334.91%) | |
| PMI Flag Ship Acquisition Corp | $19.3M | — (loss-making) | — (loss-making) | +38.62% (above 0%: growing) | n/m | +46.79% (above 0%: growing) | 20.85% | (156.70%) | Compare |
| ALUR Allurion Technologies, Inc. | $16.7M | — (loss-making) | — (loss-making) | −47.19% (below 0%: shrinking) | n/m | +65.98% (above 0%: growing) | 41.70% | (126.60%) | Compare |
| LFWD Lifeward Ltd. | $16.3M | — (loss-making) | — (loss-making) | +15.71% (above 0%: growing) | n/m | −52.77% (below 0%: shrinking) | 40.90% | (62.69%) | Compare |
| ARAY Accuray Incorporated | $14.8M | — (loss-making) | — (loss-making) | −20.87% (below 0%: shrinking) | n/m | +117.83% (above 0%: growing) | 35.22% | 5.47% | Compare |
| Median of peers | $24.6M | — | — | +10.13% | — | −13.24% | 38.06% | (94.64%) |